Outcome of Board Meeting held on April 07, 2025 for 1)Considering approving and fixing Tuesday, 15 April, 2025 as the ''Record Date'' for the purpose of determining the equity shareholders ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Remedium Lifecare Ltd (formerly Roxy Exports Limited, BSE scrip code 539561) held a board meeting on April 7, 2025, where it approved a Rights Issue of up to 49.19 crore fully paid-up equity shares of Re. 1 each, aggregating to Rs. 4,919.04 lakhs. The issue price is set at Re. 1 per share, which is at par with face value. The rights entitlement ratio is 61 shares for every 50 shares held by existing shareholders. The Board fixed Tuesday, April 15, 2025 as the Record Date to identify eligible equity shareholders entitled to receive the rights entitlements.
Eligible shareholders will need to hold shares by the April 15, 2025 record date to participate in the rights issue. Since shares are being offered at par (no discount), the main consideration for shareholders is the capital raise purpose and whether to subscribe to their entitlement ratio of 1.22x their existing holding.